IBM Secures $1 Billion from U.S. for Quantum Wafer Production

IBM's subsidiary, Anderon, has finalized a substantial $1 billion agreement with the U.S. Department of Commerce under the CHIPS program. This funding will bolster the production capabilities of quantum wafers at its Albany, New York facility.

The deal, announced in May 2026, was formalized with a letter of intent. Notably, Anderon is positioned as the first U.S. facility devoted to producing 300-mm quantum wafers, catering to multiple developers rather than a single client.

Utilizing IBM's advanced technologies and specialized equipment, the facility will focus on manufacturing wafers for superconducting qubit arrays, quantum input-output components, and readout circuits. Anderon has already begun producing its initial products and plans to broaden its offerings to support various quantum modalities.

IBM is set to contribute the full $1 billion from its own resources as part of this initiative, which aligns with its broader strategy to expand its quantum computing business. In June, the company announced an investment exceeding $10 billion in quantum technologies over the next five years, targeting research, manufacturing, and partnerships.

IBM CEO Arvind Krishna emphasized in July that these investments are expected to yield significant returns, impacting the company's revenue and profits by 2028-2029.